medRxiv
Impact of PCSK9 Inhibitors on Lipoprotein(a): A Meta-analysis and Meta-regression of Randomized Controlled Trials
Publication
, Preprint
Rivera, FB; Cha, SW; Magalong, JV; Tang, VA; Enriquez, MG; Gulati, M; Enkhmaa, B; Pagidipati, N; Shah, N
2024
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Citation
APA
Chicago
ICMJE
MLA
NLM
Rivera, F. B., Cha, S. W., Magalong, J. V., Tang, V. A., Enriquez, M. G., Gulati, M., … Shah, N. (2024). Impact of PCSK9 Inhibitors on Lipoprotein(a): A Meta-analysis and Meta-regression of Randomized Controlled Trials. medRxiv. https://doi.org/10.1101/2024.07.10.24310245
Rivera, Frederick Berro, Sung Whoy Cha, John Vincent Magalong, Vincent Anthony Tang, Mary Grace Enriquez, Martha Gulati, Byambaa Enkhmaa, Neha Pagidipati, and Nishant Shah. “Impact of PCSK9 Inhibitors on Lipoprotein(a): A Meta-analysis and Meta-regression of Randomized Controlled Trials.” MedRxiv, 2024. https://doi.org/10.1101/2024.07.10.24310245.
Rivera FB, Cha SW, Magalong JV, Tang VA, Enriquez MG, Gulati M, et al. Impact of PCSK9 Inhibitors on Lipoprotein(a): A Meta-analysis and Meta-regression of Randomized Controlled Trials. medRxiv. 2024.
Rivera, Frederick Berro, et al. “Impact of PCSK9 Inhibitors on Lipoprotein(a): A Meta-analysis and Meta-regression of Randomized Controlled Trials.” MedRxiv, 2024. Epmc, doi:10.1101/2024.07.10.24310245.
Rivera FB, Cha SW, Magalong JV, Tang VA, Enriquez MG, Gulati M, Enkhmaa B, Pagidipati N, Shah N. Impact of PCSK9 Inhibitors on Lipoprotein(a): A Meta-analysis and Meta-regression of Randomized Controlled Trials. medRxiv. 2024.